Nuwellis Prices $3.4M Offering at $2.59/Share with Warrants — Deep Discount to Market
NUWE is trading near its 52-week low of $1.61 (2.5% above the low) on elevated volume (3.0× avg).
Summary
Nuwellis priced a $3.4 million public offering at $2.59 per share — a steep discount to its $4.45 last sale — with warrants for an equal number of shares, adding substantial dilution pressure to a company already fighting for survival.
Key Events · Financing and Capital Events · NUWE
-
Deeply Discounted Offering Priced
Nuwellis is selling 1,310,890 shares at $2.59 each, a 42% discount to the July 30 closing price of $4.45, for gross proceeds of $3.4 million.
-
Warrants Double Potential Dilution
Investors receive warrants to buy an additional 1,310,890 shares at $2.59, exercisable for five years, potentially doubling the share count if exercised.
-
Net Proceeds of ~$2.9 Million
After a 9% placement agent fee ($305,568), a 0.85% management fee, and ~$84,000 in expenses, Nuwellis nets approximately $2.9 million for working capital.
-
Preliminary Revenue Growth Disclosed
The prospectus supplement reveals preliminary Q2 2026 revenue growth of 14% year-over-year and 20% for the first half of 2026, but this positive news is overshadowed by the dilutive financing.
Analysis · NUWE · Industrial Applications And Services
Nuwellis is raising $3.4 million in a deeply discounted offering priced at $2.59 per share, a 42% discount to the last reported sale price of $4.45 on July 30, 2026. The deal includes warrants for an equal number of shares at the same $2.59 exercise price, doubling the potential dilution. This follows a series of distressed financings, a recent 1-for-35 reverse stock split, and a going-concern warning. The company disclosed preliminary Q2 revenue growth of 14% year-over-year, but the offering's structure signals urgent cash needs and significant dilution risk for existing shareholders.
At the time of this filing, NUWE was trading at $1.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $633.9K. The 52-week trading range was $1.61 to $378.35. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.